Kuhn Rebecca's Insider Trades & SAST Disclosures
Kuhn Rebecca's most recent trade in NeuroPace Inc was a trade of 1,337 Common Stock done at an average price of $13.5 . Disclosure was reported to the exchange on June 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Kuhn Rebecca.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NeuroPace Inc | Rebecca Kuhn | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.54 per share. | 03 Jun 2025 | 1,337 | 131,613 | - | 13.5 | 18,103 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.66 per share. | 27 May 2025 | 357 | 132,950 | - | 12.7 | 4,520 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.99 per share. | 20 May 2025 | 3,051 | 133,307 | - | 18.0 | 54,887 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.94 per share. | 22 Apr 2025 | 237 | 136,358 | - | 10.9 | 2,593 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 19,850 | 19,850 | - | - | Stock Option (Rt to Buy) | |
| NeuroPace Inc | Rebecca Kuhn | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 11,700 | 136,595 | - | 0 | Common Stock | |
| NeuroPace Inc | Rebecca Kuhn | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.81 per share. | 03 Mar 2025 | 1,337 | 124,895 | - | 11.8 | 15,790 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.56 per share. | 27 Feb 2025 | 1,430 | 126,232 | - | 12.6 | 17,961 | Common Stock |
| NeuroPace Inc | Kuhn Rebecca | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 24,950 | 24,950 | - | - | Stock Option (Right to Buy) | |
| NeuroPace Inc | Kuhn Rebecca | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 12,500 | 152,204 | - | 0 | Common Stock | |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2023 | 80,000 | 139,704 | - | 0 | Common Stock | |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 31 Oct 2022 | 692 | 58,968 | - | 0.0 | 18 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2022 | 692 | 0 | - | - | Stock Option (Rt to Buy) | |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2022 | 482 | 0 | - | - | Stock Option (Rt to Buy) | |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 31 Oct 2022 | 482 | 59,704 | - | 0.0 | 13 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2022 | 254 | 0 | - | - | Stock Option (Rt to Buy) | |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 31 Oct 2022 | 254 | 59,222 | - | 0.0 | 7 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.50 per share. | 22 Apr 2022 | 9,832 | 133,284 | - | 17.5 | 172,060 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.10 per share. | 22 Apr 2022 | 4,019 | 146,895 | - | 4.1 | 16,478 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.23 per share. | 22 Apr 2022 | 3,405 | 127,662 | - | 14.2 | 48,453 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.98 per share. | 22 Apr 2022 | 3,045 | 128,960 | - | 8.0 | 24,299 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.24 per share. | 22 Apr 2022 | 3,045 | 124,344 | - | 7.2 | 22,046 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.19 per share. | 22 Apr 2022 | 3,045 | 119,728 | - | 9.2 | 27,984 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.46 per share. | 22 Apr 2022 | 1,334 | 127,626 | - | 6.5 | 8,618 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.39 per share. | 22 Apr 2022 | 1,334 | 123,010 | - | 7.4 | 9,858 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.93 per share. | 22 Apr 2022 | 1,334 | 118,394 | - | 11.9 | 15,915 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.99 per share. | 22 Apr 2022 | 1,042 | 132,242 | - | 16.0 | 16,662 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.11 per share. | 22 Apr 2022 | 1,010 | 145,706 | - | 4.1 | 4,151 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.93 per share. | 22 Apr 2022 | 1,010 | 144,517 | - | 8.9 | 9,019 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.90 per share. | 22 Apr 2022 | 1,010 | 143,328 | - | 8.9 | 8,989 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.32 per share. | 22 Apr 2022 | 718 | 151,486 | - | 8.3 | 5,974 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.04 per share. | 22 Apr 2022 | 265 | 118,129 | - | 14.0 | 3,721 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.65 per share. | 22 Apr 2022 | 237 | 127,389 | - | 7.6 | 1,813 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.00 per share. | 22 Apr 2022 | 237 | 122,773 | - | 6 | 1,422 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.00 per share. | 22 Apr 2022 | 237 | 132,005 | - | 14 | 3,318 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.98 per share. | 22 Apr 2022 | 212 | 150,914 | - | 3.0 | 632 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.84 per share. | 22 Apr 2022 | 212 | 143,116 | - | 14.8 | 3,146 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.02 per share. | 22 Apr 2022 | 181 | 151,126 | - | 3.0 | 547 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.55 per share. | 22 Apr 2022 | 179 | 151,307 | - | 5.5 | 993 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.25 per share. | 22 Apr 2022 | 179 | 146,716 | - | 4.3 | 761 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.13 per share. | 22 Apr 2022 | 179 | 145,527 | - | 4.1 | 739 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.88 per share. | 22 Apr 2022 | 179 | 144,338 | - | 6.9 | 1,232 | Common Stock |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 93,480 | 93,480 | - | - | Stock Option (Right to Buy) | |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 46,740 | 58,276 | - | 0 | Common Stock | |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 16,620 | 16,620 | - | - | Stock Option (Right to Buy) | |
| NeuroPace Inc | Rebecca Kuhn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 8,310 | 11,536 | - | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges